NASDAQ Careers: Find a Job Now
Web NASDAQ.com
Search
Save my stocks for next time

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

SIAL: Stock Quote & Summary Data

$ 53.94 0.06 0.11%
Nov. 20, 2009 Market Closed
Update Quotes: . Updates every 7 Seconds.
Sigma-Aldrich Corporation
SIAL | Sigma-Aldrich Corporation | Common Stock | Market : NASDAQ-GS

Last Sale
Change Net / %
Best Bid / Ask
1y Target Est: $ 60.00
Today's High / Low  / 
Share Volume
50 Day Avg. Daily Volume 780,899
Previous Close $ 53.88
52 Wk High / Low $ 56.29 / $ 31.4518
Shares Outstanding 121,814,000
Market Value $ 6,570,647,160
P/E Ratio 19.69
Forward P/E (1yr) 17.21
Earnings Per Share $ 2.74
Annualized Dividend $ 0.58
Ex Dividend Date Aug. 28, 2009
Dividend Payment Date Sep. 15, 2009
Current Yield 1.08 %
Beta 1.05
NASDAQ Official Open Price: $ 53.49
Date of NASDAQ Official Open Price: Nov. 20, 2009
NASDAQ Official Close Price: $ 53.94
Date of NASDAQ Official Close Price: Nov. 20, 2009

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

Have a Question About SIAL?

Ask your question about about Sigma-Aldrich Corporation (SIAL) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!

Hot Topics in NASDAQ Answers

The most popular questions & answers in the
NASDAQ Answers Community:


 Company Description (as filed with the SEC)

Sigma-Aldrich Corporation (“the Company”) was incorporated under the laws of the State of Delaware in May 1975. Effective July 31, 1975 (“Reorganization”), the Company succeeded, as a reporting company, Sigma International, Ltd., the predecessor of Sigma Chemical Company (“Sigma”), and Aldrich Chemical Company, Inc. (“Aldrich”), both of which had operated continuously for more than 20 years prior to the Reorganization. The Company’s principal executive offices are located at 3050 Spruce Street, St. Louis, Missouri, 63103. On February 28, 2005, the Company completed its acquisition of all of the outstanding capital securities of JRH Biosciences Pty Ltd., CSL US Inc. and JRH Biosciences Limited, which collectively comprised the JRH Biosciences division (JRH) of CSL Limited for $366.8 million. JRH is a leading global supplier of cell culture and sera products to the biopharmaceutical industry.  ... More ...  

Get ETF News, Commentary, Tools & more...

Visit the new NASDAQ.com ETFs hub Now

 Company News for SIAL

Sigma-Aldrich Launches 'What's Your Favorite Gene?' Application On Facebook(R) Platform
- PR Newswire  11/18/2009 8:00AM
Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
- PR Newswire  11/10/2009 4:12PM
Sigma-Aldrich Signs Distribution Deal With Stemgent To Offer Lentivirus-based Delivery Systems For Regenerative Medicine
- RTT News  11/10/2009 11:22AM
Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
- PR Newswire  11/10/2009 10:00AM
Sigma-Aldrich Inks License Deal With Polyplus-transfection To Offer Novel ZNA Oligonucleotides - Quick Facts
- RTT News  11/03/2009 8:19AM
Sigma-Aldrich Signs License Agreement With Polyplus-transfection to Offer Novel ZNA(TM) Oligonucleotides
- PR Newswire  11/03/2009 8:00AM
Sigma-Aldrich(R) Teams With 3M to Provide TIPS Pentacene Organic Electronics Semiconductor for Growing Printed Electronics Industry
- PR Newswire  10/29/2009 8:00AM
 

Consensus Recommendation


Analyst Info

Annual EPS Est: $ 2.77
Quarterly EPS Est: $ 0.72
PEG Ratio: 1.93
Mean Recommendation:
View Summary/View All
2.56